America’s Overmedicated Children, Presentation by Vera Sharav, Sweden

Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being drugged with powerful psychotropic drugs, most of which have not been tested in or approved for use by children. The Food and Drug Administration (FDA) acknowledges that many of these drugs have serious adverse side effects, both physical and psychological. The Comptroller said she was alarmed that in her review of a single month (November 2003), two powerful antipsychotic drugs — Risperdal and Zyprexa — made up half of the drugs prescribed to foster children in Texas. These two drugs have been approved only for adults for the treatment of psychosis – primarily schizophrenia – yet, she found that children as young as four, were receiving these powerful, mind-altering drugs.

Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations

THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Proposed Changes to Subpart D Regulations Increase Risks to Children in Non-Therapeutic Research Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations April 18, 2005 The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What…

Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations

The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What is the Best Way to Protect Children?”

Our recommendation – which is backed up by evidence that children have suffered harm in medical research – is to significantly limit the discretion of IRBs to approve greater than minimal risk research without direct benefit for the child-subjects under 46.406.

We recommend staying the course in requiring that any such proposed experiment undergo a transparent open evaluation with ample opportunity for public oversight and comment – as required under the provisions of 46.407.

Pfizer Marketing Scheme Stirs Concern/ Corporate Responsibility Movement Puts PhRMA on Notice

Pfizer Marketing Scheme Stirs Concern_NYT / Corporate Responsibility Movement Puts PhRMA on Notice_ ICCR Mon, 7 Mar 2005 The New York Times reports that Pfizer is planning to lock up the market for heart treaments by bundling its new drug (toretrapib, which is still in experimental stage of development) to…

Texas Foster Care Investigation – Children as young as 3 are drugged with antipsychotics

Texas Foster Care Investigation – Children as young as 3 are drugged with antipsychotics Sat, 13 Nov 2004 The Dallas Morning News reports that Texas comptroller, Carole Keeton Strayhorn, who hade conducted an investigation of the foster care system, concluded that up to $4 million a year might be wasted…

Sen Domenici Blasts NIH doctors calling them "pigs" – The Hill

Sen Domenici Blasts NIH doctors calling them “pigs” – The Hill Thu, 18 Mar 2004 The shameful revelations of insatiable greed among medical researchers at the National Institutes of Health has disgusted Sen. Pete Domenici, one of the strongest supporters of medical research. “I hate to say it, but the…

Researchers Chastise Am J Psychiatry Over Skewed Celexa Study

Researchers Chastise Am J Psychiatry Over Skewed Celexa Study Thu, 31 Mar 2005 A letter by eight medical scientists (most from India, possibly all psychiatrists) have seriously challenged the scientific validity of an article published in the American Journal of Psychiatry. The lead author of the challenged study is one…

NAMI & Eli Lilly partners in bankrupting state Medicaid budgets – NYT

NAMI & Eli Lilly partners in bankrupting state Medicaid budgets – NYT Sat, 20 Dec 2003 The New York Times reports that Medicaid expenditure for prescription drugs has escalated to $27.5 billion. These costs are up 19% from last year. Antipsychotic drugs, such as Eli Lilly’s Zyprexa, eat up more…

AHRP Correspondence with Government Agencies

AHRP Correspondence with Government Agencies related link: FDA response to AHRP procedural questions (FDA sham conflicts of interest policy) FDA re: supression of SSRI evidence ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave, Suite 28P New York, NY 10023 https://ahrp.org Tel: 212-595-8974 e-mail: October 29, 2003 To: Thomas…

Debate: Ethics of Surgically Implanting Drug Device in psychiatric patients

Debate: Ethics of Surgically Implanting Drug Device in psychiatric patients Wed, 5 Nov 2003 An AHRP Infomail (October 7, 2003) criticizing the ethics of University of Pennsylvania’s planned surgical “drug implant” experiment in psychiatric patients, prompted a debate between AHRP president, Vera Sharav, and bioethicist, Paul Root Wolpe, Ph.D., University…